Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cytogenetics.

C Mecucci1, H Van den Berghe

  • 1Institute of Hematology, University of Perugia, Italy.

Hematology/Oncology Clinics of North America
|June 1, 1992
PubMed
Summary
This summary is machine-generated.

Myelodysplastic syndromes (MDS) were poorly understood until clonal evidence emerged. Research now reveals MDS comprises distinct cytogenetic entities, some linked to specific clinical conditions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A novel germline mutation in CDK4 codon 24 associated to familial melanoma.

Clinical genetics·2017
Same author

Blastic plasmacytoid dendritic cell neoplasm and chronic myelomonocytic leukemia: a shared clonal origin.

Leukemia·2017
Same author

NUP98-fusion transcripts characterize different biological entities within acute myeloid leukemia: a report from the AIEOP-AML group.

Leukemia·2016
Same author

Translocation (14;19)(q32;q13.1) in a Young Patient who Developed a Large Cell Lymphoma after an Initial Diagnosis of CLL.

Leukemia & lymphoma·2016
Same author

Two Translocations: a Follicular Variant 2; 18 and a Burkitt 8;14 in a Small Non Cleaved Non Hodgkin's Lymphoma.

Leukemia & lymphoma·2016
Same author

The importance of cytogenetic and molecular analyses in eosinophilia-associated myeloproliferative neoplasms: an unusual case with normal karyotype and TNIP1- PDGFRB rearrangement and overview of PDGFRB partner genes.

Leukemia & lymphoma·2016
Same journal

Palliative Therapy for Liver and Biliary Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Ablative Therapies for Liver Tumors.

Hematology/oncology clinics of North America·2026
Same journal

Pathology of Liver and Biliary Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Minimally Invasive Surgery for Liver and Biliary Tract Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Surgical Considerations for Primary Liver Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Systemic Therapy for Biliary and Liver Neoplasms: Chemotherapy and Immunotherapy.

Hematology/oncology clinics of North America·2026
See all related articles

Area of Science:

  • Hematology
  • Oncology
  • Genetics

Background:

  • Myelodysplastic syndromes (MDS) were historically ill-defined hematologic disorders.
  • MDS was considered premalignant due to progression to acute leukemia.
  • Early cytogenetic studies in the 1970s provided the first evidence of clonality in MDS.

Purpose of the Study:

  • To elucidate the nature of Myelodysplastic syndromes.
  • To understand the clonal basis of MDS.
  • To identify distinct cytogenetic entities within MDS.

Main Methods:

  • Cytogenetic investigations.
  • Clonal analysis.
  • Clinical correlation studies.

Main Results:

Related Experiment Videos

  • Cytogenetic investigations confirmed the clonal origin of MDS.
  • MDS has been shown to encompass multiple cytogenetic entities.
  • Specific cytogenetic entities are associated with clinically distinct disorders.

Conclusions:

  • MDS is a clonal disorder.
  • Cytogenetic classification is crucial for understanding MDS heterogeneity.
  • Further research into MDS cytogenetics can inform clinical management.